ProQR Therapeutics N.V. buy Cantor Fitzgerald
Start price
29.04.25
/
50%
€1.38
Target price
29.04.26
€7.02
Performance (%)
-5.95%
End price
30.04.26
€1.30
Summary
This prediction ended on 30.04.26 with a price of €1.30. With a performance of -5.95%, the BUY prediction by Cantor_Fitzgerald finished with a loss. Cantor_Fitzgerald has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | -4.461% | -4.461% | -14.390% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by Cantor_Fitzgerald for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $8.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten
Current prediction by Cantor_Fitzgerald for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.84
27.06.25
27.06.25
€6.84
27.06.26
27.06.26
-28.11%
05.06.26
05.06.26
